The EDQM has warned manufacturers that hold Certificates of Suitability (CEP) of a new scam that asks for a fee for inclusion in a directory.
Bend Research says the addition of a new 18mm extruder to its hot melt tech will cut costs and will allow it work with customers earlier in the drug development process.
The US FDA will have more powers to inspect ‘risky’ overseas pharmaceutical plants according to supporters of a bill being considered by the US senate this week.
Contract manufacturer Recipharm says a new loan will fund strategic acquisitions and investment in manufacturing facilities.
Lonza is targeting the gene therapy sector through a new partnership with Avalanche Biotechnologies that will seek to outlicense viral vector tech and process development knowhow.
US CRO Pharmaceutical Product Development (PPD) predicts that new CEO Dave Simmons' ‘pharmaceutical industry experience’ gained at Pfizer will be an asset in guiding partnerships.